Screener
Quest Diagnostics DGX Q2 2026 earnings
Reported July 23, 2026 · Before market open
Revenue$3.0BBeat by $70.3M
Adjusted EPS$3.12Beat by $0.30
Revenue estimate$3.0B
EPS estimate$2.82
“Revenues increased by over 10%, almost all from organic revenue growth across our physician, hospital and consumer channels, and adjusted diluted EPS grew over 19%. With strong growth and sustained demand for our diagnostic insights, we are again raising our full year guidance.”
Next report
Oct 20, 2026 (in 2 months)Revenue estimate$3.0B
EPS estimate$2.85
Segments
By segment
Versus estimates
Revenue
Q2 2026$3.0BBeat by $70.3M
Q1 2026$2.9BBeat by $66.5MQ4 2025$2.8BBeat by $51.8MQ4 2024$2.6BBeat by $42.5MDiluted EPS
Q2 2026$3.12Beat by $0.30
Q1 2026$2.50Beat by $0.13Q4 2025$2.42Beat by $0.06Q4 2024$2.23Beat by $0.04FAQ
- When did Quest Diagnostics report Q2 2026 earnings?
- Quest Diagnostics (DGX) reported Q2 2026 earnings on July 23, 2026 before market open.
- What were Quest Diagnostics's Q2 2026 revenue and EPS?
- Quest Diagnostics reported revenue of $3.0B and adjusted eps of $3.12 for Q2 2026.
- Did Quest Diagnostics beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $3.0B by $70.3M. EPS beat the consensus estimate of $2.82 by $0.30.
- Where can I find Quest Diagnostics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001022079-26-000067) and the 10-Q periodic report (0001022079-26-000070) directly on SEC EDGAR. The filing index links above go to sec.gov.
